EndoSphere is the industry's first pioneer to focus on treating the Duodenum as the body's Metabolic Control Center.
EndoSphere's Founder &
Chief Medical Officer
Kenneth Binmoeller, MD is among the most published researchers and key opinion leaders in the fields of gastroenterology and endoscopy, having authored more than 300 research papers, articles and books. An accomplished entrepreneur, Dr. Binmoeller has made meaningful contributions to medicine through his past device inventions in use around the world today. In 2015, Boston Scientific acquired for $75 million his prior company, Xlumena, which developed minimally-invasive devices for Endoscopic Ultrasound guided transluminal drainage of targeted gastrointestinal tract tissues. Dr. Binmoeller is the former Director of Endoscopy at University of California - San Diego, Director of Endoscopy for California Medical Center in San Francisco, and Venture Partner at Broadline Capital. Dr. Binmoeller explains the science behind EndoSphere's technology in his keynote presentation at an international medical conference:
“EndoSphere’s exciting device presents a non-surgical solution for the millions of people struggling to lose weight, demonstrating to be less invasive than bariatric surgery and more effective than diet and exercise."
— Damian Garde, Editor
FierceMedicalDevices
Contact us.
Chris Thorne, Chairman
EndoSphere
4449 Easton Way, 2nd Floor
Columbus, OH 43219